Where is eTheRNA headquartered?

eTheRNA is located in Niel, antwerp.

Who invested in eTheRNA?

eTheRNA has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for eTheRNA?

eTheRNA closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

etherna.be

eTheRNA

eTheRNA is a Belgium-based biotechnology company that develops and commercializes mRNA immunotherapies for the treatment of cancer.

Business Model:

Revenue: $4M

Employees: 11-50

Geographic Data

Address: Galileilaan 19

City: Niel

State: antwerp

Zip: 2845

Country: BE

Financial Info

Stage:

series b

Raised Last:

$39M

Raised Total:

$112M

Social

Facebook

Twitter

Crunchbase

Metrics

4,870,897Website Global Rank

1,810Website Monthly Traffic

Twitter Followers

Description

eTheRNA is a Belgium-based biotechnology company that develops and commercializes mRNA immunotherapies for the treatment of cancer.

Contact Phone:
+13233691740

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
8/2022	Series B		$38.9M	Novalis LifeSciences LLC Life Sciences Partners ParticipatieMaatschappij Vlaanderen (PMV) NV Fund+ Omega Funds
6/2020	Series B		$38.2M	Life Sciences Partners ParticipatieMaatschappij Vlaanderen (PMV) NV Boehringer Ingelheim Venture Fund Fund+ Omega Funds Healthcare Holdings Ltd BNP Paribas Yijing Capital Novalis LifeSciences LLC
9/2017	Grant		$0	The Institute for the Promotion of Innovation by Science and Technology in Flanders The Institute for the Promotion of Innovation by Science and Technology in Flanders
6/2020	Series B		$0	BNP Paribas Private Equity Boehringer Ingelheim Venture Fund China Grand Pharmaceutical and Healthcare Holdings Fund+ LSP Novalis LifeSciences Omega Funds PMV Yijing Capital BNP Paribas Private Equity Boehringer Ingelheim Venture Fund China Grand Pharmaceutical and Healthcare Holdings Fund+ LSP Novalis LifeSciences Omega Funds PMV Yijing Capital
3/2021	Grant	1	$6.9M	European Commission European Commission
9/2017	Grant		$1.2M	Flanders Innovation & Entrepreneurship
8/2022	Series B		$0	Fund+ Grand Pharma Kenneth Chien EQT life science Novalis LifeSciences Omega Funds PMV Fund+ Grand Pharma Kenneth Chien EQT life science Novalis LifeSciences Omega Funds PMV
3/2021	Grant		$8.2M
3/2016	Series A		$26.7M	Life Sciences Partners PMV Omega Funds Fund+ Boehringer Ingelheim Venture Fund
3/2016	Series A	4	$26.6M	EQT life science PMV Omega Funds Boehringer Ingelheim Venture Fund EQT life science PMV Omega Funds Boehringer Ingelheim Venture Fund
8/2022	Series B	7	$38.7M	Fund+ Grand Pharma Kenneth Chien Life Sciences Partners Novalis LifeSciences Omega Funds PMV Fund+ Grand Pharma Kenneth Chien Life Sciences Partners Novalis LifeSciences Omega Funds PMV
6/2020	Series B	9	$38.3M	BNP Paribas Private Equity Boehringer Ingelheim Venture Fund China Grand Pharmaceutical and Healthcare Holdings Fund+ LSP Novalis LifeSciences Omega Funds PMV Yijing Capital BNP Paribas Private Equity Boehringer Ingelheim Venture Fund China Grand Pharmaceutical and Healthcare Holdings Fund+ LSP Novalis LifeSciences Omega Funds PMV Yijing Capital
9/2017	Grant	1	$1.2M	The Institute for the Promotion of Innovation by Science and Technology in Flanders The Institute for the Promotion of Innovation by Science and Technology in Flanders
3/2016	Series A	4	$26.6M	Life Sciences Partners PMV Life Sciences Partners PMV

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details